MGC Pharma gets approval in South Africa for Phase IIb Covid-19 drug trial
The anti-inflammatory and immune-modulatory effects of CimetrA will be evaluated in the trial.

The anti-inflammatory and immune-modulatory effects of CimetrA will be evaluated in the trial.
The companies will invest to develop an eco-system of uniform LMS, QMS, CTMS tools to offer a smooth experience to…
The Phase I trial will analyse for safety and immunogenicity of the mRNA HIV vaccine antigen in African populations.
The CRO will carry out data and statistical assessment to determine the relative risks of Covid-19 and severe disease.
Two clinical trials will be conducted in the US and South Africa to assess intranasal doses of IGM-6268.
Over the last five years, the conduct of clinical research in Africa has shown a steady increase, but the level…
ByThe trial will assess the tolerability, safety, efficacy and PK of two varying doses of suramin in adult LCS patients.
The gaping inequity in global vaccination rates only ensures that new Covid-19 variants such as Omicron will continue to emerge.
ByThank you for subscribing to Clinical Trials Arena